Related Experiment Videos

1H MR spectroscopy in patients with mesial temporal epilepsy

M Hájek1, M Dezortová, V Komárek

  • 1Magnetic Resonance Unit, Department of Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. miha@medicon.cz

Magma (New York, N.Y.)
|February 10, 1999
PubMed

Insights

Proton magnetic resonance spectroscopy (1H MRS) is crucial for diagnosing mesial temporal lobe epilepsy (MTLE) by detecting decreased N-acetylaspartate levels. This non-invasive technique aids in identifying epileptogenic lesions and evaluating new anti-epileptic drugs.

Area of Science:

  • Neurology
  • Medical Imaging
  • Biochemistry

Background:

  • Mesial temporal lobe epilepsy (MTLE) often originates from hippocampal sclerosis.
  • Non-invasive diagnosis of epileptogenic lesions is critical for patient management.

Purpose of the Study:

  • To review proton magnetic resonance spectroscopy (1H MRS) procedures and findings in MTLE.
  • To highlight the role of 1H MRS in diagnosing MTLE and guiding epilepsy surgery.

Main Methods:

  • Review of basic examination procedures and results of 1H MRS in MTLE patients.
  • Analysis of metabolite levels (N-acetylaspartate, NAA/Cr, NAA/Cho) and other compounds (GABA, inositol, lactate, glutamine, glutamate).

Main Results:

  • Significantly decreased N-acetylaspartate levels and related ratios (NAA/Cr, NAA/Cho) characterize epileptogenic lesions in MTLE.
  • 1H MRS can detect bilateral involvement of mesial temporal structures.
  • MRS facilitates the study of various metabolites involved in epilepsy pathochemistry.

Conclusions:

  • 1H MRS is a valuable non-invasive tool for diagnosing MTLE and identifying epileptogenic lesions.
  • 1H MRS aids in evaluating new anti-epileptic agents and contributes to pre-operative assessment for epilepsy surgery.

Related Concept Videos